{"ticker": {"uuid": "72be05a1-645b-4461-92f2-b776ddee3ee3", "symbol": "AYJ", "name": "Valneva SE", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Ixiaro by Valneva SE - Japanese encephalitis shot for serious travelers", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNOG1lajA4SXM4bnIzcExRRnZuVWhnZTBwVWRIRjZDLTZtR1VOcVBtckpkX291T19zeUxmZ1pZQXNaSVhSV3RmTGxHWm1NU1UtSTMxM1lfdERxTmJqcXdxZUxDTU9PMFJFcHlWSmJqOUZ3NENKam04WUZoc2VtQWJyNjlHM18tazZMOFFjMjFlQVVDa0p6SFFzXzFHMC1JVk9RbXBHdWRKNDR3TTY0ZG9CeWZSVmg4YVhqZlVKYlc3RHZlQ05LZkhF?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T06:39:58+00:00", "published_display": "11 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva (Nasdaq: VALN) holders approve AGM items and elect new chair", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSzVxWWJIdmFOOVdEUjhxaUVkQlBCUXBlTnFWa3JUaHJlZmZYYU5hSlpydnZoRW1Cci1DTGRPdzg5LVNqdWtZQjVacnpJZGRFOUlndmNHR0ZWRndYWGJ5VzFHcFo1OG43VGlDWFRTam9tRVdvbHRfcTdOQS1Ha2Z1MkJXOWJyVHU4YmgtdFhMS050eHJyYTN6VTZOTHVZRjJRYmFvUGNZSV9aQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Valneva SE Q1 2026 reports revenue decline, stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPMVhJNWNQbi1WbjNnZVR3UVBrdTY0eVdTQ2tZWmJ1YlRWM2doWjAxb0owX3JTUFA3TFE3T05VU3Y5R2VOX1BVWVZfVjV6S0JsTHlHVlhQR1VaQkN4d0h3N0JmTnJfSWllWGRNek5NMGQyNFBKcldyTV9HYTJSMzEzWkxKNndMU1BFclZFbnd2dkZEaUZFaUk0aE5GWUJCNlFVSTNzSFk2QVZTWDRnUXp3dlZWOGVoenFaa1ByZUVUZDBKUENHX2xOWVo1NVdISDQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva in the green despite guidance cut and restructuring", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxObHhra19UT25BaE5BQ3JZdGoxd1NLWHpNQzFCMGFCNU1sWE9Uc2hwYWpEeU1jMW81aGstQ2l3ckkybTIyV3FCRkhSVFdlYUg3bGE2aC1neV9LUVFHczJZazZnWEVqazdReUZVclJzMlplSlVjOUpmTGIxY0VvVWJIZ3g3TlltckNYbXI1bVdETnFZeTlMaUNpZG1NbXlmdzNPZEZiR3E0cUJPazNRQzNyRmJB?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares tumble after suspension of US chikungunya vaccine licence", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQc2VCMkRjeWowR3c2anRFaGd2d1lMTWZuTU9LRVdBZEhYVUQ3Ukhab0FxNExUSG14ZHotVVY1R2dkOS0tenpIYUM1OXZ5V3pEbXJpNlhldERTYjBPUks2RGgwMmdiZmMyTHJXWWU0ZFQ1ODRJZm5ia1B6ekxyY1UtU1JmZHlaOE1uaTU1eWQyZ1RkMFVBOHNKTWMtTEp0MUpEbTdLdEJCU3ExRzVVbEhvNUpwRWM3S0x6SmRlRzhZRmdXRmdHVDZ6RzZiYjc4MHRoaGxIX2E5elY?oc=5", "source_name": "Reuters", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Vaccine for a Mosquito-Borne Disease Fuels Valneva Stock Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPOFJDNlg4NGE1aFRNVDl1SGd5bUFPamp2SmdsQUxrSDBHS1BKODZNUmczVW5wdzVSNGZhVFByN05BZDhaaWctUG9aN0FWRXRNS2U3anhLT19wSHFkd2xsLVFhZmhFckFYaGhoRGFvY0tId1puOE9JNXdpMFVIWW1sZEp5VzUtQ3ZSbU0zRi1xRjl1S2d4NXN0WHI3ckJvclUwWFJJcXNpS0FOMVdtUDNvaEtXcmZDdw?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-08-14T07:00:00+00:00", "published_display": "14 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares fall as French health body advises against its COVID-19 vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcU1EMm9uTmwwYTlyTEdTOW80bWRNRTJNdUxwQVh3UmQtNFJfQzBwY3VOSHROMzdQMk5hV0xuTEI4aUFKZ2w2TEdUby1DbmJiUWdXcTJIdnExU2lDVUdUR2M2WmsydWFTUXNMSE5vVjF1NFlINjFfRld0WDdzcDNvY1h0ckwzVUF6eG94dGZaRG54TkdXVFZXNVF2QzFIX1FrRDlQQkljVHNHN2pYdXpyOUhIMjlpX2tiNzAyWURnTFpza0EtdXY4VDcxV1ZyV09teEM3LWpVQ2MwOGlGRHA0dg?oc=5", "source_name": "Reuters", "published_at": "2022-12-08T08:00:00+00:00", "published_display": "08 Dec 2022 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Plunges After U.K. Scraps Covid Vaccine Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPV1BxS0k5cHpxUFJWbjlTMU1WSmdJRXVSNDRzV28xTlVzMmRTSzZod2RVTHlzNjkxZlNmZ1gydWcyMlctdWk5b1Z4TDFLMlY2OGJxcGFmSUFOVDZCYlNDVHVQWmo2SUpKeTlId29ubWR0UGEwRDQ4aEEzVWpULTV1WUZRejRTVVN1QmVtV1J1bWNMdG9EeVBpOGFLMGxqQ01VNUNWWWxfcU9haXFWRWc?oc=5", "source_name": "Bloomberg.com", "published_at": "2021-09-13T07:00:00+00:00", "published_display": "13 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Ixiaro by Valneva SE - Japanese encephalitis shot for serious travelers", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNOG1lajA4SXM4bnIzcExRRnZuVWhnZTBwVWRIRjZDLTZtR1VOcVBtckpkX291T19zeUxmZ1pZQXNaSVhSV3RmTGxHWm1NU1UtSTMxM1lfdERxTmJqcXdxZUxDTU9PMFJFcHlWSmJqOUZ3NENKam04WUZoc2VtQWJyNjlHM18tazZMOFFjMjFlQVVDa0p6SFFzXzFHMC1JVk9RbXBHdWRKNDR3TTY0ZG9CeWZSVmg4YVhqZlVKYlc3RHZlQ05LZkhF?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T06:39:58+00:00", "published_display": "11 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva (Nasdaq: VALN) holders approve AGM items and elect new chair", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSzVxWWJIdmFOOVdEUjhxaUVkQlBCUXBlTnFWa3JUaHJlZmZYYU5hSlpydnZoRW1Cci1DTGRPdzg5LVNqdWtZQjVacnpJZGRFOUlndmNHR0ZWRndYWGJ5VzFHcFo1OG43VGlDWFRTam9tRVdvbHRfcTdOQS1Ha2Z1MkJXOWJyVHU4YmgtdFhMS050eHJyYTN6VTZOTHVZRjJRYmFvUGNZSV9aQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Valneva SE Q1 2026 reports revenue decline, stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPMVhJNWNQbi1WbjNnZVR3UVBrdTY0eVdTQ2tZWmJ1YlRWM2doWjAxb0owX3JTUFA3TFE3T05VU3Y5R2VOX1BVWVZfVjV6S0JsTHlHVlhQR1VaQkN4d0h3N0JmTnJfSWllWGRNek5NMGQyNFBKcldyTV9HYTJSMzEzWkxKNndMU1BFclZFbnd2dkZEaUZFaUk0aE5GWUJCNlFVSTNzSFk2QVZTWDRnUXp3dlZWOGVoenFaa1ByZUVUZDBKUENHX2xOWVo1NVdISDQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva in the green despite guidance cut and restructuring", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxObHhra19UT25BaE5BQ3JZdGoxd1NLWHpNQzFCMGFCNU1sWE9Uc2hwYWpEeU1jMW81aGstQ2l3ckkybTIyV3FCRkhSVFdlYUg3bGE2aC1neV9LUVFHczJZazZnWEVqazdReUZVclJzMlplSlVjOUpmTGIxY0VvVWJIZ3g3TlltckNYbXI1bVdETnFZeTlMaUNpZG1NbXlmdzNPZEZiR3E0cUJPazNRQzNyRmJB?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares tumble after suspension of US chikungunya vaccine licence", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQc2VCMkRjeWowR3c2anRFaGd2d1lMTWZuTU9LRVdBZEhYVUQ3Ukhab0FxNExUSG14ZHotVVY1R2dkOS0tenpIYUM1OXZ5V3pEbXJpNlhldERTYjBPUks2RGgwMmdiZmMyTHJXWWU0ZFQ1ODRJZm5ia1B6ekxyY1UtU1JmZHlaOE1uaTU1eWQyZ1RkMFVBOHNKTWMtTEp0MUpEbTdLdEJCU3ExRzVVbEhvNUpwRWM3S0x6SmRlRzhZRmdXRmdHVDZ6RzZiYjc4MHRoaGxIX2E5elY?oc=5", "source_name": "Reuters", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Vaccine for a Mosquito-Borne Disease Fuels Valneva Stock Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPOFJDNlg4NGE1aFRNVDl1SGd5bUFPamp2SmdsQUxrSDBHS1BKODZNUmczVW5wdzVSNGZhVFByN05BZDhaaWctUG9aN0FWRXRNS2U3anhLT19wSHFkd2xsLVFhZmhFckFYaGhoRGFvY0tId1puOE9JNXdpMFVIWW1sZEp5VzUtQ3ZSbU0zRi1xRjl1S2d4NXN0WHI3ckJvclUwWFJJcXNpS0FOMVdtUDNvaEtXcmZDdw?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-08-14T07:00:00+00:00", "published_display": "14 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares fall as French health body advises against its COVID-19 vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcU1EMm9uTmwwYTlyTEdTOW80bWRNRTJNdUxwQVh3UmQtNFJfQzBwY3VOSHROMzdQMk5hV0xuTEI4aUFKZ2w2TEdUby1DbmJiUWdXcTJIdnExU2lDVUdUR2M2WmsydWFTUXNMSE5vVjF1NFlINjFfRld0WDdzcDNvY1h0ckwzVUF6eG94dGZaRG54TkdXVFZXNVF2QzFIX1FrRDlQQkljVHNHN2pYdXpyOUhIMjlpX2tiNzAyWURnTFpza0EtdXY4VDcxV1ZyV09teEM3LWpVQ2MwOGlGRHA0dg?oc=5", "source_name": "Reuters", "published_at": "2022-12-08T08:00:00+00:00", "published_display": "08 Dec 2022 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Plunges After U.K. Scraps Covid Vaccine Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPV1BxS0k5cHpxUFJWbjlTMU1WSmdJRXVSNDRzV28xTlVzMmRTSzZod2RVTHlzNjkxZlNmZ1gydWcyMlctdWk5b1Z4TDFLMlY2OGJxcGFmSUFOVDZCYlNDVHVQWmo2SUpKeTlId29ubWR0UGEwRDQ4aEEzVWpULTV1WUZRejRTVVN1QmVtV1J1bWNMdG9EeVBpOGFLMGxqQ01VNUNWWWxfcU9haXFWRWc?oc=5", "source_name": "Bloomberg.com", "published_at": "2021-09-13T07:00:00+00:00", "published_display": "13 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 62, "total_relevant": 8, "sentiment_summary": {"positive": 0, "negative": 3, "neutral": 5, "score": 43, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 3.8, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.19, "latest_week": "2026-07-10", "one_week_move": -6.2, "four_week_move": -4.8, "twelve_week_move": -15.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.605888, "market_dynamics_buy_signal": false, "relative_strength": -40.89732, "fair_value_gap": -40.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.7391, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.2% over one week, -4.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Reuters", "count": 2}, {"label": "Bloomberg.com", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Earnings", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "43/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.2% over one week, -4.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Ixiaro by Valneva SE - Japanese encephalitis shot for serious travelers"}], "updated_at": "2026-07-17T10:45:40.055222+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}